The global demand for Peripheral Artery Revascularisation Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020 - 2026.
Peripheral artery disease refers to atherosclerotic occlusive disease of the lower extremities. Other terms used for this disorder are peripheral arterial occlusive disease, peripheral vascular disease, and more moderate extremity arterial disease. The condition can be treated with either surgical and non-surgical options or a combination of both. Peripheral artery revascularization is performed to treat limb ischemia or prevent major limb ischemic events. Revascularization can be performed endovascular or surgical. New promising treatment options such as gene therapy and others are under research; the study's positive response will favor its popularity.
The rising global prevalence of peripheral artery disease (PAD) and the growing aging population contribute to the significant growth of the peripheral artery revascularisation market. Peripheral arterial disease (PAD) is an important manifestation of atherosclerosis, which in 2015 was estimated to affect more than 236.5 million people worldwide. The number of people with the disease is projected to increase at a double-digit rate with high prevalence in low- and high-income countries. With the aging of the global population and the incidence of risk factors such as diabetes, hypertension, obesity, and tobacco use, it seems likely that PAD will be increasingly common in the future. The burden appears to be higher among men than women for more severe or symptomatic disease. Despite a considerable burden and high-risk equivalent, these patients are overlooked, and only one-fourth of patients are submitted to treatment. There is a lack of interest in the routine examination of the PAD, which hinders the market's growth.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of peripheral artery revascularisation.
The entire peripheral artery revascularisation market has been sub-categorized into product and distribution channel. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By Distribution Channel
- Lower Extremity Revascularisation
- Renal Arterial Revascularisation
- Mesenteric Arterial Revascularisation
- Abdominal Aortic Revascularisation
- Specialty Clinics
This section covers regional segmentation which accentuates on current and future demand for peripheral artery revascularisation market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Peripheral Artery Revascularisation Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the peripheral artery revascularisation market include Abbott Laboratories, Cardinal Health, C. R. Bard, Medtronic, Cook Medical, AngioDynamics, Boston Scientific Corporation, Terumo Corporation, Philips Healthcare. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.